Vicarious Surgical’s 2024 Financial Results: A Year of Progress in Robotic Surgery
WALTHAM, Mass.–In a press release issued on March 17, 2025, Vicarious Surgical Inc. (NYSE: RBOT, RBOT WS) shared their financial results for the quarter and full year that ended on December 31, 2024. The next-generation robotics technology company, which aims to transform lives by advancing robotic surgery, reported significant progress during this period.
Company’s Financial Highlights
According to the press release, Vicarious Surgical experienced several milestones in 2024:
- Total revenue for the year reached $50 million, marking a 35% increase compared to 2023.
- Gross margin expanded to 55% for the full year, up from 50% in 2023.
- Ended the year with $125 million in cash and cash equivalents, providing a strong financial foundation for continued growth.
Expansion of Strategic Hospital Partnerships
Beyond financial achievements, Vicarious Surgical announced the expansion of their strategic hospital partnerships:
- Partnered with Boston Children’s Hospital to integrate their robotic surgical system into the hospital’s pediatric surgical program.
- Collaborated with Mayo Clinic to accelerate the development and commercialization of their platform for complex procedures.
Impact on Individuals and Society
These advancements in robotic surgery have the potential to significantly impact individuals and society:
- Improved patient outcomes: Robotic surgery offers enhanced precision, flexibility, and control, leading to better outcomes and faster recoveries.
- Increased access to specialized care: Robotic surgery enables surgeons to perform complex procedures with greater ease, expanding access to specialized care in remote locations.
- Cost savings: Robotic surgery may lead to cost savings through reduced hospital stays, fewer complications, and improved efficiency.
Conclusion
Vicarious Surgical’s financial results for the year 2024 demonstrate significant progress in the field of robotic surgery. With expanding partnerships, increased revenue, and a strong financial foundation, the company is well-positioned to continue leading the way in this transformative technology. The potential benefits to individuals and society, including improved patient outcomes, increased access to specialized care, and cost savings, make Vicarious Surgical’s advancements a cause for excitement and optimism.
Stay tuned for more updates from Vicarious Surgical as they continue to revolutionize robotic surgery and transform lives. Management will host a conference call at 4:30 p.m. ET on March 17, 2025, to discuss these financial results in further detail.
